30. Note to the Cash Flow Statement
(thousands of €) |
2025 |
2024 |
|---|---|---|
Adjustment for non-cash transactions |
|
|
Amortization, depreciation and impairment on intangible assets and property, plant and equipment |
55,875 |
45,499 |
Share-based compensation expenses |
23,999 |
19,886 |
Decrease in retirement benefit obligations |
(2,352) |
(524) |
Unrealized exchange losses/gains (-) and non-cash other financial result |
43,836 |
(23,858) |
Discounting effect of non-current deferred income |
– |
(227) |
Discounting effect of other non-current liabilities |
1,183 |
(395) |
Discounting effect of contingent consideration receivable |
(2,676) |
(4,002) |
Fair value re-measurement of warrants |
– |
(4) |
Net change in fair value of current financial investments |
51,911 |
(49,984) |
Fair value adjustment financial assets held at fair value through profit or loss |
(1,175) |
– |
Fair value adjustment contingent consideration receivable |
(11,887) |
(931) |
Fair value adjustment of contingent consideration payable |
(21,760) |
– |
Impairment loss (addition/reversal (-)) on trade receivables |
(9,643) |
9,643 |
Other non-cash expenses |
(151) |
(12) |
Total adjustment for non-cash transactions |
127,160 |
(4,909) |
|
|
|
Adjustment for items to disclose separately under operating cash flow |
|
|
Interest expense |
1,034 |
912 |
Interest income |
(46,339) |
(89,378) |
Income taxes |
(18,138) |
(1,705) |
Cash used for other liabilities related to the disposal of subsidiaries |
– |
527 |
Total adjustment for items to disclose separately under operating cash flow |
(63,443) |
(89,644) |
|
|
|
Adjustment for items to disclose under investing and financing cash flows |
|
|
Gain on sale of subsidiaries |
(1,085) |
(52,488) |
Loss on sale of fixed assets |
27 |
8 |
Proceeds from settlement of hedging instrument |
(22,745) |
– |
Investment income on financial investments |
(33,645) |
(23,759) |
Cash used for other liabilities related to the disposal of subsidiaries |
15,194 |
– |
Total adjustment for items to disclose separately under investing and financing cash flow |
(42,254) |
(76,239) |
|
|
|
Change in working capital other than deferred income |
|
|
Decrease in inventories |
28,851 |
23,039 |
Increase (-)/decrease in receivables |
86,588 |
(31,055) |
Increase/decrease (-) in liabilities |
33,813 |
(53,429) |
Total change in working capital other than deferred income |
149,252 |
(61,445) |